Ceribell is a pioneering medical technology company dedicated to revolutionizing the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, an innovative point-of-care electroencephalography (EEG) platform that addresses critical needs in acute care settings. This technology is currently utilized in numerous community hospitals, large academic institutions, and major integrated delivery networks across the United States. Ceribell's mission is driven by a commitment to enhance critical care through rapid seizure detection technology, making a significant impact on patient outcomes.